MedTrace Logo

Aggreguide A-100 ADP Assay Evaluation

NCT02112539 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2017-04-04

No results posted yet for this study

Summary

The study is to characterize the AggreGuide ADP Assay's performance.

Conditions

  • Platelet Aggregation
  • ADP Blockers

Interventions

OTHER

platelet aggregation measurement

Sponsors & Collaborators

  • Aggredyne, Inc.

    lead INDUSTRY

Principal Investigators

  • Edward Teitel, MD · Unafilliated

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2014-08-31
Completion
2014-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02112539 on ClinicalTrials.gov